ARCHIVES

Clearinghouse Exec. Secty, Says It Has Failed in Its Objectives, Recommends It Be Dropped

This article is from The Cancer Letter archive.

Vol. 04 No. 02 | January 13, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

Stereo Mammography Detects More Lesions, Study Finds

December 28, 2007

Study Validates “PEM” Scans As Biopsy Guidance Method

April 29, 2011

Commemoration Planned For Heidelberger

February 11, 1983

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001